Výsledky vyhledávání - Xiaoting Wei

  • Zobrazuji výsledky 1 - 6 z 6
Upřesnit hledání
  1. 1
    Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study

    Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study Autor Lili Mao, Meiyu Fang, Yu Chen, Xiaoting Wei, Jun Cao, Jing Lin, Peng Zhang, Ling Chen, Xiao Cao, Yujun Chen, Jun Guo, Lu Si

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis

    Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis Autor Jie Dai, Tianxiao Xu, Lifeng Li, Meiyu Fang, Jing Lin, Jun Cao, Xue Bai, Caili Li, Xiaoting Wei, Junjie Gu, Yaoyao Liu, Xuan Gao, Xuefeng Xia, Jun Guo, Yu Chen, Lili Mao, Lu Si

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights

    Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights Autor Xuan Wang, Hui Tian, Zhihong Chi, Lu Si, Xinan Sheng, Han Hu, Xiangyong Gu, Siming Li, Caili Li, Bin Lian, Li Zhou, Lili Mao, Bixia Tang, Xieqiao Yan, Xiaoting Wei, Juan Li, Binlei Liu, Jun Guo, Yan Kong, Chuanliang Cui

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma

    Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma Autor Lili Mao, Bin Lian, Caili Li, Xue Bai, Li Zhou, Chuanliang Cui, Zhihong Chi, Xinan Sheng, Xuan Wang, Bixia Tang, Xieqiao Yan, Siming Li, Yan Kong, Jie Dai, Xiaoting Wei, Juan Li, Rong Duan, Huayan Xu, Xiaowen Wu, Yue Yang, Fengzhuo Cheng, Cheng Zhang, Fangzhou Xia, Pan Zheng, Jun Guo, Lu Si

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma

    The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma Autor Xiaoting Wei, Di Wu, Hang Li, Rui Zhang, Yu Chen, Hong Yao, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Xue Bai, Zhonghui Qi, Ke Li, Shijie Lan, Lizhu Chen, Rui Guo, Xinyu Yao, Lili Mao, Bin Lian, Yan Kong, Jie Dai, Bixia Tang, Xieqiao Yan, Xuan Wang, Siming Li, Li Zhou, Charles M. Balch, Lu Si, Jun Guo

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

    Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy Autor Xue Bai, Jiani Hu, Allison Betof Warner, Henry T. Quach, Christopher Cann, Michael Zhang, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Lalit Pallan, Catriona Harvey, Michael P. Manos, Olivia Ouyang, Michelle S. Kim, Gyulnara G. Kasumova, Justine V. Cohen, Donald P. Lawrence, Christine Freedman, Riley Fadden, Krista M. Rubin, Tatyana Sharova, Dennie T. Frederick, Keith T. Flaherty, Osama E. Rahma, Georgina V. Long, Alexander M. Menzies, Jun Guo, Alexander N. Shoushtari, Douglas B. Johnson, Ryan J. Sullivan, Genevieve M. Boland

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: